NCT01766726View on ClinicalTrials.gov

Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients

CompletedOBSERVATIONAL

Enrollment

33

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

HIV

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Gilead Sciences

All Listed Sponsors

collaborator

Gilead Sciences

INDUSTRY

lead

Massachusetts General Hospital

OTHER